HO-1 protects against obesity-induced insulin resistance through the degradation of pro-oxidant heme and the production of carbon monoxide and bilirubin, which have anti-inflammatory properties. This evidence concerns the gene HMOX1 and obesity due to melanocortin 4 receptor deficiency.